Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Genpact (G) Capital Expenditures (2016 - 2025)

Genpact has reported Capital Expenditures over the past 17 years, most recently at $17.7 million for Q4 2025.

Quarterly results put Capital Expenditures at $17.7 million for Q4 2025, down 10.44% from a year ago — trailing twelve months through Dec 2025 was $78.2 million (down 5.51% YoY), and the annual figure for FY2025 was $78.2 million, down 5.51%.
Capital Expenditures for Q4 2025 was $17.7 million at Genpact, up from $16.3 million in the prior quarter.
Over the last five years, Capital Expenditures for G hit a ceiling of $24.0 million in Q1 2024 and a floor of $7.3 million in Q2 2021.
Median Capital Expenditures over the past 5 years was $16.5 million (2022), compared with a mean of $16.0 million.
Biggest five-year swings in Capital Expenditures: plummeted 42.69% in 2021 and later skyrocketed 90.85% in 2024.
Genpact's Capital Expenditures stood at $22.0 million in 2021, then tumbled by 30.31% to $15.3 million in 2022, then rose by 18.23% to $18.1 million in 2023, then grew by 8.99% to $19.7 million in 2024, then fell by 10.44% to $17.7 million in 2025.
The last three reported values for Capital Expenditures were $17.7 million (Q4 2025), $16.3 million (Q3 2025), and $22.2 million (Q2 2025) per Business Quant data.